Infectious Disease Diagnostic Market

Infectious Disease Diagnostic Market by Products (Consumables [Assays and Reagents], Software & Services, and Instruments & Analyzers), Technology (Molecular Diagnostic Techniques, and Traditional Diagnostic Techniques), Applications (Hepatitis C, Hepatitis B, Tuberculosis (TB), Acquired Immunodeficiency Syndrome (AIDS), Human Papillomavirus (HPV), and Methicillin-resistant Staphylococcus Aureus (MRSA)), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021–2028

  • Report ID: HC-651
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 147
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global infectious disease diagnostic market size is anticipated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the growing prevalence of various infectious diseases across the globe.

Infectious diseases include malaria, TB, HIV/AIDS, hepatitis, HAIs, STDs, diarrheal diseases, among others. The prevalence of infectious diseases leads to increasing morbidity and mortality across the globe. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. The outbreak of COVID-19 pandemic has affected the global infectious disease diagnostic market in several ways. The outbreak resulted in major shortage of diagnostic kits to test for the Sars-Cov-2 infection. On the other hand, diagnostic virology entities are under immense pressure to develop reliable testing kits.

There is a substantial need to identify suitable diagnostic technique owing to the evolving pathogens and emergence of new diseases. These diagnostic techniques help the physicians to decide the appropriate treatment for the disease. There is a significant change in the performance of rapid diagnostics tests owing to the continuous research and development activities in techniques such as mass spectrometry and next-generation sequencing (NGS). The point-of-care diagnostics offer various actionable data for patients care and treatment. There is a significant shift in focus from centralized laboratories to decentralized point-of-care testing along with increase in funding for research on infectious diseases.

Global Infectious Disease Diagnostic Market Summary

Market Drivers, Restraints, Trends, and Opportunities

  • Growing inclination of end-user towards point-of-care testing is projected to spur the market growth during the forecast period.
  • Prevalence of infectious diseases such as HPV, hepatitis, HIV and tuberculosis are increasing across the globe, thereby driving the infectious disease diagnostic market growth.
  • Increasing demand for rapid diagnostic techniques as compared to the current techniques owing to the long result time and supportive government funding is expected to drive the market growth.
  • Budgetary consideration between the healthcare systems is a key challenge for implementing the novel diagnostic techniques in clinical laboratories owing to low reimbursements for these tests.
  • Reduction in reimbursements policies is projected to negatively impact the adoption of molecular and genetic testing, which is further expected to hamper the market growth.
  • Growing preference of consumers towards the benefits of personalized medicine is projected to boost the use of molecular diagnostic and genomics & proteomics technologies.
  • Availability of genetic & molecular tests enables the early detection of diseases and provides personalized treatment. This is expected to ensure substantial savings in treatment costs.
  • Increasing demand for clinical microbiology services business have boosted the business growth in the recent years.

Scope of the Report

The report on the global infectious disease diagnostic market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Infectious Disease Diagnostic Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Consumables [Assays and Reagents], Software & Services, and Instruments & Analysers), Technology (Molecular Diagnostic Techniques, and Traditional Diagnostic Techniques), and Applications (Hepatitis C, Hepatitis B, Tuberculosis (TB), Acquired Immunodeficiency Syndrome (AIDS), Human Papillomavirus (HPV), and Methicillin-resistant Staphylococcus Aureus (MRSA))

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories. Alere Inc, Danaher Corporation, and Johnson and Johnson.

 

Global Infectious Disease Diagnostic Market Segment Insights

Consumables segment is projected to represent a considerable market share
On the basis of products, the market is categorized into consumables, software & services, and instruments & analyzers. The consumables segment is further divided into assays and reagent. The consumables segment is projected to represent a considerable market share during the forecast period. The availability of a diverse range of assays & reagents for diagnosis of various disease and their expense. Additionally, the outbreak COVID-19 is projected to fuel the market growth as there is a huge requirement of various kits and assays. Roche, bioMerieux and Bio-Rad are some of the key industry participants for assays, kits & reagents in the infectious disease diagnostics market.

Molecular diagnostic techniques segment to constitute a large market share
In terms of technology, the market is bifurcated into molecular diagnostic techniques and traditional diagnostic techniques. The molecular diagnostic techniques segment is anticipated to constitute a large market share during the forecast period. The molecular diagnostic technique segment is further categorized into INAAT (Isothermal Nucleic Acid Amplification Test), Polymerase Chain Reaction (PCR), NGS & DNA sequencing, hybridization, and microarrays. The growth in sequencing technology, rise in awareness of personalized medicine and increasing application in pharmacogenetics and point-of-care testing is projected to fuel the segment growth during the forecast period.

Recently, NGS sequencing segment has gained significant traction in drug discovery and pharmacogenetics. There is a considerable change in the development, testing and targeting of new medicines. Recent technological advancements and reducing prices of NGS based tests is anticipated to further propel the segment growth. Furthermore, the PCR and INAAT based tests hold a considerable market share. The PCR is a reaction process that generates multiple images of DNA from a particular DNA sequence. The traditional diagnostic technique segment is expected to expand at a healthy CAGR during the forecast period. The segment is further classified into biochemical characterization, microscopy, and immunodiagnostics.

Global Infectious Disease Diagnostic Market By Technology

Tuberculosis (TB) segment is expected to account for a significant market share
Based on applications, the market is categorized into Hepatitis C, Hepatitis B, Tuberculosis (TB), Acquired Immunodeficiency Syndrome (AIDS), Human Papillomavirus (HPV), and Methicillin-resistant Staphylococcus Aureus (MRSA). The TB segment is expected to account for a significant market share during the forecast period. TB usually occurs due to mycobacterium tuberculosis. The growing number of TB cases across the globe is driving the segment growth.

Global Infectious Disease Diagnostic Market By Application

North America region is anticipated to represent a large market share.
In terms of regions, the market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to represent a large market share during the forecast period. The presence of a large number of the patient population in this region is propelling the regional growth of the infectious disease diagnostic market. Additionally, growing investment in the healthcare infrastructure, and several government initiatives is projected to further boost the market growth in this region. On the other, the market in Asia Pacific is estimated to expand at a high CAGR during the forecast period. The increasing prevalence of infectious diseases, and rise in patient awareness is driving the market in the Asia Pacific region.

Global Infectious Disease Diagnostic Market By Region

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Infectious Disease Diagnostic Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Infectious Disease Diagnostic Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Infectious Disease Diagnostic Market - Supply Chain
  4.5. Global Infectious Disease Diagnostic Market Forecast
     4.5.1. Infectious Disease Diagnostic Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Infectious Disease Diagnostic Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Infectious Disease Diagnostic Market Absolute $ Opportunity
5. Global Infectious Disease Diagnostic Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Infectious Disease Diagnostic Market Size and Volume Forecast by Applications
     5.3.1. Hepatitis C
     5.3.2. Hepatitis B
     5.3.3. Tuberculosis (TB)
     5.3.4. Acquired Immunodeficiency Syndrome (AIDS)
     5.3.5. Human Papillomavirus (HPV)
     5.3.6. Methicillin-resistant Staphylococcus Aureus (MRSA)
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Infectious Disease Diagnostic Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Infectious Disease Diagnostic Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Infectious Disease Diagnostic Demand Share Forecast, 2019-2026
7. North America Infectious Disease Diagnostic Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Infectious Disease Diagnostic Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Infectious Disease Diagnostic Market Size and Volume Forecast by Applications
     7.4.1. Hepatitis C
     7.4.2. Hepatitis B
     7.4.3. Tuberculosis (TB)
     7.4.4. Acquired Immunodeficiency Syndrome (AIDS)
     7.4.5. Human Papillomavirus (HPV)
     7.4.6. Methicillin-resistant Staphylococcus Aureus (MRSA)
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Infectious Disease Diagnostic Demand Share Forecast, 2019-2026
8. Latin America Infectious Disease Diagnostic Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Infectious Disease Diagnostic Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Infectious Disease Diagnostic Market Size and Volume Forecast by Applications
     8.4.1. Hepatitis C
     8.4.2. Hepatitis B
     8.4.3. Tuberculosis (TB)
     8.4.4. Acquired Immunodeficiency Syndrome (AIDS)
     8.4.5. Human Papillomavirus (HPV)
     8.4.6. Methicillin-resistant Staphylococcus Aureus (MRSA)
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Infectious Disease Diagnostic Demand Share Forecast, 2019-2026
9. Europe Infectious Disease Diagnostic Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Infectious Disease Diagnostic Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Infectious Disease Diagnostic Market Size and Volume Forecast by Applications
     9.4.1. Hepatitis C
     9.4.2. Hepatitis B
     9.4.3. Tuberculosis (TB)
     9.4.4. Acquired Immunodeficiency Syndrome (AIDS)
     9.4.5. Human Papillomavirus (HPV)
     9.4.6. Methicillin-resistant Staphylococcus Aureus (MRSA)
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Infectious Disease Diagnostic Demand Share Forecast, 2019-2026
10. Asia Pacific Infectious Disease Diagnostic Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Infectious Disease Diagnostic Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Infectious Disease Diagnostic Market Size and Volume Forecast by Applications
     10.4.1. Hepatitis C
     10.4.2. Hepatitis B
     10.4.3. Tuberculosis (TB)
     10.4.4. Acquired Immunodeficiency Syndrome (AIDS)
     10.4.5. Human Papillomavirus (HPV)
     10.4.6. Methicillin-resistant Staphylococcus Aureus (MRSA)
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Infectious Disease Diagnostic Demand Share Forecast, 2019-2026
11. Middle East & Africa Infectious Disease Diagnostic Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Infectious Disease Diagnostic Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Infectious Disease Diagnostic Market Size and Volume Forecast by Applications
     11.4.1. Hepatitis C
     11.4.2. Hepatitis B
     11.4.3. Tuberculosis (TB)
     11.4.4. Acquired Immunodeficiency Syndrome (AIDS)
     11.4.5. Human Papillomavirus (HPV)
     11.4.6. Methicillin-resistant Staphylococcus Aureus (MRSA)
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Infectious Disease Diagnostic Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Infectious Disease Diagnostic Market: Market Share Analysis
  12.2. Infectious Disease Diagnostic Distributors and Customers
  12.3. Infectious Disease Diagnostic Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Bio Mérieux SA
     12.4.2. Roche Diagnostics
     12.4.3. Abbott Laboratories
     12.4.4. Thermo Fischer Scientific, Inc.
     12.4.5. Becton
     12.4.6. Dickinson & Company
     12.4.7. Bio-Rad Laboratories
     12.4.8. Alere Inc
     12.4.9. Dan
Segments Covered in the Report
The global infectious disease diagnostic market has been segmented on the basis of

Products
  • Consumables
    • Assays
    • Reagents
  • Software & Services
  • Instruments & Analyzers
Technology
  • Molecular Diagnostic Techniques
  • Traditional Diagnostic Techniques
Applications
  • Hepatitis C
  • Hepatitis B
  • Tuberculosis (TB)
  • Acquired Immunodeficiency Syndrome (AIDS)
  • Human Papillomavirus (HPV)
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key players
  • Bio Mérieux SA
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fischer Scientific, Inc.
  • Becton
  • Dickinson & Company
  • Bio-Rad Laboratories
  • Alere Inc
  • Danaher Corporation
  • Johnson and Johnson

Some of the key players in the global infectious disease diagnostic market include Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories. Alere Inc, Danaher Corporation and Johnson and Johnson. The industry participants are providing their focus on research and development activities to generate point-of-care diagnostics solutions for emerging economies.

Global Infectious Disease Diagnostic Market By Key Players

Buy Report